CD5+成熟T细胞淋巴瘤的患病率和预后
Omar Elghawy1, Miao Cao1,2, Jason Xu1
1Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Cancers
|October 16, 2024
概括
集群分化5 (CD5) 表达在T细胞淋巴瘤 (TCL) 中很常见. 虽然CD5+状态不是TCL的普遍预后标志物,但与TFHTCL和ATLL等特定亚型的较差结果有关.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- T细胞淋巴瘤 (TCLs) 呈现异质的临床行为和有限的风险分层工具.
- 差异化集群5 (CD5) 的预后作用已在B细胞淋巴瘤中确立,但在TCL中仍然没有特征.
研究的目的:
- 研究CD5在各种T细胞淋巴瘤亚型中的表达.
- 评估CD5表达与TCL患者的临床结果 (包括生存) 之间的关联.
主要方法:
- 对194名新诊断的T细胞淋巴瘤患者的回顾性分析.
- 通过免疫组织化学和/或流细胞计评估的CD5阳性.
- 单变量和多变量分析用于将生物因素与生存相关联.
主要成果:
- 在63%的TCL患者中观察到CD5表达,特别高于TFHTCL (93.9%),PTCL-NOS (82.9%) 和ATLL (77.8%).
- CD5阳性与年龄较大,晚期 (III/IV) 和骨髓干扰相关.
- 虽然总生存率 (OS) 和无进展生存率 (PFS) 在队列中没有受到CD5状态的显著影响,但CD5+TFH TCL和CD5+ATLL显示了显著下降的OS.
结论:
- 这项研究是首次确定CD5表达作为T细胞淋巴瘤潜在的预后生物标志物.
- 在常见的结节TCL亚型中,CD5的频繁表达表明它有可能成为细胞治疗的目标.
- 需要在更大的队列和机制研究中进行进一步的验证来证实这些发现.
关键词:
阿特尔公司 (ATLL)CD5 CD5 CD5 CD5 CD5 CD5 CD5 CD5 CD5 CD5 CD5 CD5 CD5 CD5 CD5 CD5 CD5 CD5 CD5在PTCL中,PTCL就是PTCL.这是一种T细胞淋巴瘤.细胞标记物 细胞标记物流动细胞计量是流动细胞计量的方法.结果就是结果.预测和预测是指预测.更多相关视频
10:18From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
13.7K
09:08Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
5.4K
相关概念视频
01:22T Cell Activation and Clonal Selection
679
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
679
01:24T Cell Types and Functions
959
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
959